共 16 条
- [1] THE SPECIFIC DOPAMINE AGONIST, LY171555, DECREASES NOREPINEPHRINE CONTENT OF POSTERIOR HYPOTHALAMUS IN THE NORMOTENSIVE RAT BUT NOT IN THE DOCA/NACL HYPERTENSIVE RAT CLINICAL RESEARCH, 1986, 34 (01): : A218 - A218
- [2] THE SPECIFIC DOPAMINE AGONIST, LY171555, SELECTIVELY INCREASES DOPAMINE CONTENT OF ANTERIOR HYPOTHALAMUS IN DOCA/NACL HYPERTENSIVE RAT CLINICAL RESEARCH, 1986, 34 (01): : A188 - A188
- [4] HYPERTENSIVE DOCA/NACL RATS EXHIBIT REDUCED PRESSOR-RESPONSE TO THE SPECIFIC DOPAMINE (D2) AGONIST, LY171555 CLINICAL RESEARCH, 1986, 34 (01): : A188 - A188
- [5] MECHANISM OF THE PRESSOR ACTION OF LY171555, A SPECIFIC DOPAMINE-D2 RECEPTOR AGONIST, IN THE CONSCIOUS RAT JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1986, 236 (03): : 735 - 742
- [6] LY171555, A SELECTIVE DOPAMINE D2 RECEPTOR AGONIST, INHIBITS INVIVO STRIATAL DOPAMINE RELEASE IN NORMOTENSIVE AND HYPERTENSIVE RATS CLINICAL RESEARCH, 1986, 34 (01): : A177 - A177
- [8] RAPID DESENSITIZATION OF THE CENTRAL PRESSOR ACTION OF LY171555, A SPECIFIC DOPAMINE-D2 RECEPTOR AGONIST IN CONSCIOUS RAT CLINICAL RESEARCH, 1986, 34 (02): : A400 - A400
- [9] MECHANISM OF THE DEPRESSOR ACTION OF LY171555, A SELECTIVE DOPAMINE D2 RECEPTOR AGONIST, IN THE ANESTHETIZED RAT JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1986, 239 (02): : 426 - 432